Florida S1092 regulates podiatric physicians performing stem cell therapy, requiring informed consent and facility certification.
Florida S1092 amends podiatric medicine regulations to allow podiatric physicians to perform stem cell therapy not approved by the FDA under specific conditions. The bill mandates that physicians obtain informed consent from patients, detailing the therapy's nature, risks, and alternatives. It requires facilities providing stem cells to be certified or accredited by specified organizations and to notify physicians of any use of placental stem cells. The bill also outlines disciplinary actions and criminal penalties for violations, emphasizing ethical standards in stem cell therapy.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.